SE8904332L - Farmaceutisk beredning foer bekaempning av patogena tarmbakterier - Google Patents

Farmaceutisk beredning foer bekaempning av patogena tarmbakterier

Info

Publication number
SE8904332L
SE8904332L SE8904332A SE8904332A SE8904332L SE 8904332 L SE8904332 L SE 8904332L SE 8904332 A SE8904332 A SE 8904332A SE 8904332 A SE8904332 A SE 8904332A SE 8904332 L SE8904332 L SE 8904332L
Authority
SE
Sweden
Prior art keywords
pct
pharmaceutical preparation
man
sec
pathogenic microorganisms
Prior art date
Application number
SE8904332A
Other languages
English (en)
Other versions
SE465206B (sv
SE8904332D0 (sv
Inventor
Eva Grahn
Stig Holm
Original Assignee
Eva Grahn
Stig Holm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eva Grahn, Stig Holm filed Critical Eva Grahn
Priority to SE8904332A priority Critical patent/SE465206B/sv
Publication of SE8904332D0 publication Critical patent/SE8904332D0/sv
Priority to PCT/SE1990/000850 priority patent/WO1991009608A1/en
Priority to DK91901938.0T priority patent/DK0506817T3/da
Priority to JP03502116A priority patent/JP3140049B2/ja
Priority to AU70482/91A priority patent/AU641722B2/en
Priority to CA002070687A priority patent/CA2070687C/en
Priority to DE69025953T priority patent/DE69025953T2/de
Priority to AT91901938T priority patent/ATE135228T1/de
Priority to ES91901938T priority patent/ES2084806T3/es
Priority to US07/861,796 priority patent/US5322686A/en
Priority to EP91901938A priority patent/EP0506817B1/en
Publication of SE8904332L publication Critical patent/SE8904332L/sv
Publication of SE465206B publication Critical patent/SE465206B/sv
Priority to FI922825A priority patent/FI96744C/sv
Priority to NO922379A priority patent/NO303620B1/no

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/54Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals combined with metals, oxides or hydroxides provided for in groups B01J23/02 - B01J23/36
    • B01J23/56Platinum group metals
    • B01J23/62Platinum group metals with gallium, indium, thallium, germanium, tin or lead
    • B01J23/622Platinum group metals with gallium, indium, thallium, germanium, tin or lead with germanium, tin or lead
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1236Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using Leuconostoc, Pediococcus or Streptococcus sp. other than Streptococcus Thermophilus; Artificial sour buttermilk in general
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/10Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J27/00Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
    • B01J27/06Halogens; Compounds thereof
    • B01J27/08Halides
    • B01J27/10Chlorides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C5/00Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms
    • C07C5/22Preparation of hydrocarbons from hydrocarbons containing the same number of carbon atoms by isomerisation
    • C07C5/2206Catalytic processes not covered by C07C5/23 - C07C5/31
    • C07C5/226Catalytic processes not covered by C07C5/23 - C07C5/31 with metals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2521/00Catalysts comprising the elements, oxides or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium or hafnium
    • C07C2521/02Boron or aluminium; Oxides or hydroxides thereof
    • C07C2521/04Alumina
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2523/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00
    • C07C2523/14Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of germanium, tin or lead
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2523/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00
    • C07C2523/38Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of noble metals
    • C07C2523/40Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of noble metals of the platinum group metals
    • C07C2523/42Platinum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2523/00Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00
    • C07C2523/38Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of noble metals
    • C07C2523/54Catalysts comprising metals or metal oxides or hydroxides, not provided for in group C07C2521/00 of noble metals combined with metals, oxides or hydroxides provided for in groups C07C2523/02 - C07C2523/36
    • C07C2523/56Platinum group metals
    • C07C2523/62Platinum group metals with gallium, indium, thallium, germanium, tin or lead
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/885Streptococcus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Materials Engineering (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Husbandry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dairy Products (AREA)
  • Fodder In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
SE8904332A 1989-12-22 1989-12-22 Farmaceutisk beredning foer bekaempning av patogena tarmbakterier SE465206B (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE8904332A SE465206B (sv) 1989-12-22 1989-12-22 Farmaceutisk beredning foer bekaempning av patogena tarmbakterier
EP91901938A EP0506817B1 (en) 1989-12-22 1990-12-19 Pharmaceutical preparation for controlling pathogenic intestinal bacteria
DE69025953T DE69025953T2 (de) 1989-12-22 1990-12-19 Pharmazeutische zubereitung zur kontrolle pathogener intestinaler bakterien
ES91901938T ES2084806T3 (es) 1989-12-22 1990-12-19 Preparacion farmaceutica para el control de bacterias intestinales patogenas.
JP03502116A JP3140049B2 (ja) 1989-12-22 1990-12-19 病原性腸内細菌をコントロールするための医薬製剤
AU70482/91A AU641722B2 (en) 1989-12-22 1990-12-19 Pharmaceutical preparation for controlling pathogenic intestinal bacteria
CA002070687A CA2070687C (en) 1989-12-22 1990-12-19 Pharmaceutical preparation for controlling pathogenic intestinal bacteria
PCT/SE1990/000850 WO1991009608A1 (en) 1989-12-22 1990-12-19 Pharmaceutical preparation for controlling pathogenic intestinal bacteria
AT91901938T ATE135228T1 (de) 1989-12-22 1990-12-19 Pharmazeutische zubereitung zur kontrolle pathogener intestinaler bakterien
DK91901938.0T DK0506817T3 (da) 1989-12-22 1990-12-19 Farmaceutisk præparat til kontrol med patogene intestinale bakterier
US07/861,796 US5322686A (en) 1989-12-22 1990-12-19 Pharmaceutical preparation for controlling pathogenic intestinal bacteria
NO922379A NO303620B1 (no) 1989-12-22 1992-06-17 FremgangsmÕte for fremstilling av et farmas°ytisk preparat for bekjempelse av patogene mikroorganismer i mennesker og dyr
FI922825A FI96744C (sv) 1989-12-22 1992-06-17 Förfarande för framställning av en farmaceutisk beredning för bekämpning av patogena mikroorganismer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8904332A SE465206B (sv) 1989-12-22 1989-12-22 Farmaceutisk beredning foer bekaempning av patogena tarmbakterier

Publications (3)

Publication Number Publication Date
SE8904332D0 SE8904332D0 (sv) 1989-12-22
SE8904332L true SE8904332L (sv) 1991-06-23
SE465206B SE465206B (sv) 1991-08-12

Family

ID=20377846

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8904332A SE465206B (sv) 1989-12-22 1989-12-22 Farmaceutisk beredning foer bekaempning av patogena tarmbakterier

Country Status (13)

Country Link
US (1) US5322686A (sv)
EP (1) EP0506817B1 (sv)
JP (1) JP3140049B2 (sv)
AT (1) ATE135228T1 (sv)
AU (1) AU641722B2 (sv)
CA (1) CA2070687C (sv)
DE (1) DE69025953T2 (sv)
DK (1) DK0506817T3 (sv)
ES (1) ES2084806T3 (sv)
FI (1) FI96744C (sv)
NO (1) NO303620B1 (sv)
SE (1) SE465206B (sv)
WO (1) WO1991009608A1 (sv)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705152A (en) * 1990-10-26 1998-01-06 Interprise Limited Antimicrobial composition
ATE161181T1 (de) * 1992-07-06 1998-01-15 Nestle Sa Lactobacillus acidophilus enthaltende antigastritis-mittel
US5478557A (en) * 1992-07-29 1995-12-26 The United States Of America, As Represented By The Secretary Of Agriculture Probiotic for control of salmonella
US5714378A (en) * 1995-03-31 1998-02-03 The United States Of America As Represented By The Secretary Of The Navy Pseudomonas chlororaphis microorganism polyurethane degrading enzyme obtained therefrom and method of using enzyme
AT405235B (de) * 1995-11-02 1999-06-25 Helmut Dr Viernstein Probiotisch wirksame formulierung
GR1002668B (el) * 1996-03-15 1997-04-14 N Μεθοδος προσθηκης στειρου αεριου αζωτου και φαρμακολογικως δραστικων ουσιων εις στερεο γιαουρτι.
US5902578A (en) * 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
RU2164801C1 (ru) * 1999-12-06 2001-04-10 Дочернее государственное унитарное экспериментально-производственное предприятие "Вектор-Биальгам" Препарат-пробиотик в сухой иммобилизованной форме
KR20030065463A (ko) * 2000-08-11 2003-08-06 데이비드 알. 휘트록 질소 산화물 및 질소 산화물 전구체의 생산을 증가시키기위한 암모니아 산화 박테리아를 포함하는 조성물 및 이를이용하는 방법
CN1308438C (zh) * 2002-01-11 2007-04-04 大卫·R·怀特洛克 含有氨氧化细菌的化合物以及使用的方法
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050152884A1 (en) * 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
FR2883131B1 (fr) * 2005-03-16 2007-04-27 Sarl Caribou T G Sarl Procede de preparation de grains de kefir, et application aux installations de preparation de soupes pour animaux d'elevage
EP2261323A1 (en) * 2005-05-31 2010-12-15 The Iams Company Feline probiotic lactobacilli
AU2006253007B2 (en) * 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
RU2436581C2 (ru) 2007-02-01 2011-12-20 Дзе Иамс Компани Способ уменьшения воспаления и снижения стресса у млекопитающего
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2349295B8 (en) * 2008-11-17 2016-12-14 Winclove Holding B.V. Pharmaceutical preparation comprising a combination of streptococcus strains and lactobacillus strains
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
KR20210100224A (ko) 2014-04-15 2021-08-13 에이오바이오미 엘엘씨 암모니아-산화 니트로소모나스 유트로파 균주 d23
US11225640B2 (en) 2014-04-15 2022-01-18 Aobiome Llc Ammonia oxidizing bacteria for treatment of psoriasis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1190386A (en) * 1966-06-28 1970-05-06 Green Cross Corp Process for producing the Lactic Acid Bacteria Drugs
SU1333709A1 (ru) * 1985-11-29 1987-08-30 Всесоюзный Научно-Исследовательский Институт Молочной Промышленности Штамм SтRертососсUS LастIS,используемый в заквасках дл приготовлени кисломолочных продуктов
JPS62201823A (ja) * 1986-02-28 1987-09-05 Freunt Ind Co Ltd 腸内有用細菌含有物およびその製造方法
SU1423586A1 (ru) * 1986-06-09 1988-09-15 Институт Микробиологии И Вирусологии Ан Казсср Способ приготовлени закваски "Казахсил" дл силосовани кормов
US5143845A (en) * 1986-09-03 1992-09-01 Toa Pharmaceutical Co., Ltd. Mixture of saccarifying lactic acid producing and butyric acid producing bacteria
JP2612001B2 (ja) * 1987-09-04 1997-05-21 フロイント産業株式会社 腸内有用細菌含有顆粒およびその製造方法
AU4055689A (en) * 1988-08-03 1990-03-05 Wisconsin Alumni Research Foundation Biological inoculant effective against aphanomyces

Also Published As

Publication number Publication date
NO303620B1 (no) 1998-08-10
FI922825L (sv) 1992-06-17
EP0506817A1 (en) 1992-10-07
EP0506817B1 (en) 1996-03-13
WO1991009608A1 (en) 1991-07-11
US5322686A (en) 1994-06-21
DE69025953D1 (de) 1996-04-18
SE465206B (sv) 1991-08-12
CA2070687C (en) 2001-04-10
FI96744C (sv) 1996-08-26
JPH05502873A (ja) 1993-05-20
AU641722B2 (en) 1993-09-30
NO922379D0 (no) 1992-06-17
FI922825A0 (sv) 1992-06-17
DE69025953T2 (de) 1996-09-05
DK0506817T3 (da) 1996-04-15
NO922379L (no) 1992-08-12
AU7048291A (en) 1991-07-24
ATE135228T1 (de) 1996-03-15
SE8904332D0 (sv) 1989-12-22
FI96744B (sv) 1996-05-15
JP3140049B2 (ja) 2001-03-05
CA2070687A1 (en) 1991-06-23
ES2084806T3 (es) 1996-05-16

Similar Documents

Publication Publication Date Title
SE8904332D0 (sv) Farmaceutisk beredning foer bekaempning av patogena tarmbakterier
Moellering Jr Emergence of Enterococcus as a significant pathogen
EP0353581A3 (en) Pharmaceutical compositions comprising selected lactobacillus strains
NZ506058A (en) Antibacterial 9-substituted tetracyclines, and pharmaceuticals and uses thereof
PL299543A1 (en) Anti-gastritis and anti-ulcerous agent, biologically active culture of lactic acid bacteria strain and composition containing such agent
DK1005353T3 (da) Farmaceutisk præparat omfattende Lactobacillus casei rhamnosus
DE69839699D1 (de) Vaginales lactobacillus-medikament
EP0276132A3 (en) Strain of microorganism having antimicrobial activity strain of microorganism having antimicrobial activity
UA43366C2 (uk) Штам бактерій pseudomonas chlororaphis або його біологічно чисті культури, здатні продукувати активні антипатогенні метаболіти, композиція для профілактики захворювань рослин, спосіб профілактики захворювань рослин
AU6453596A (en) Fungicidal mixtures
KR950007861A (ko) 항종양제
ATE118674T1 (de) Bioherbizide, die chemische wirkstoffe und pflanzenpathogene bakterien kombinieren.
Russell et al. Comparative sensitivity and resistance of some strains of Pseudomonas aeruginosa and Pseudomonas stutzeri to antibacterial agents
Esteban et al. Isolation of Nocardia sp. from blood cultures in a teaching hospital
FR2739867B1 (fr) Milieux selectifs de culture et d'isolement des bacteries gram-, composition antibiotique
PT852497E (pt) Utilizacao de derivados de prostano e a sua combinacao com antibioticos no tratamento de infeccoes bacterianas
Brauner et al. Pseudomonas cepacia septicemia in patients with burns: report of two cases
Whitehouse et al. Isolation of Simonsiella sp. from a neonate
ES8104402A1 (es) Procedimiento para la preparacion de medicamentos inmunobio-terapicos a partir de cepas microbiologicas.
RU92015133A (ru) Консорциум бактерий (lactobacillus salivarius var. salivaris lactobacillus acidophilus, lactobacillus lactis) 3843 для активации фотосинтеза
CA2114629A1 (en) Receptor conjugates for targeting antibiotics to bacteria
RU92015134A (ru) Консорциум бактерий (lactobacillus salivarius var. salivaris syreptococcusthermophilus streptococcus bovis) 3844 для активации прорастания семян
HUT70477A (en) Leukotriene-b4 derivatives, process for preparing the same and medicaments contg. them cont. the same
Omelyanets et al. Effect of Pseudomonas aureofaciens on certain processes of microbial self-purification of soil.
KR950029350A (ko) 유제품으로부터 비피도박테리아의 선발과 계수를 위한 특정 숙주감염 특이성을 지닌 파지가 함유된 선택배지

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8904332-7

Format of ref document f/p: F